On 5 December 2019, Jiangsu Bioperfectus Technologies Company, Ltd. (herein referred to as "JBTC") was listed on the STAR Market (Science and Technology Innovation Board, SSE).
JBTC is located in China Medical City, which is a national high-tech region focusing on medical innovation. JBTC specializes in the R&D, production and purchasing of molecular diagnostic devices and reagents, providing corresponding IVD services, which is its overall business model. JBTC is a professional innovative manufacturing enterprise that is oriented in molecular diagnostic techniques. During a decade, JBTC has become a critical supplier for diagnostic products in the field of disease prevention & control as well as clinical gynecologic oncology screenings.
Llinks assisted JBTC as its legal adviser, helping to complete initial public offering.
